Valproic acid Completed Phase 2 Trials for Androgenetic Alopecia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01548066The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss